This filing contains no new information beyond a routine reaffirmation of existing guidance. Monitor the next quarterly earnings release for any actual performance versus these targets.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 11 $429.48entry
- T+1 · 5d ago +0.10%α +0.45% · $429.90
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Elevance Health filed an 8-K to reaffirm its full-year 2026 guidance during investor meetings. The company expects GAAP EPS of at least $22.00 and adjusted EPS of at least $29.00, with a benefit expense ratio of 90.2% plus or minus 50 basis points. This is a routine reaffirmation of prior guidance with no new financial data.
Key Facts
- Full-year 2026 GAAP EPS guidance reaffirmed at at least $22.00 per diluted share
- Full-year 2026 adjusted EPS guidance reaffirmed at at least $29.00 per diluted share
- Full-year 2026 benefit expense ratio guidance reaffirmed at 90.2% plus or minus 50 basis points
- Guidance includes approximately $7.00 per diluted share of net unfavorable items
Financial Impact
No new financial data; prior guidance reaffirmed with no change to EPS or expense ratio ranges
Risk Factors
- Forward-looking statements subject to risks including healthcare cost trends, enrollment changes, and regulatory shifts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001156039-26-000074 |
| Document: 0001156039-26-000074-index-headers.html | 0001156039-26-000074 |
| Document: 0001156039-26-000074-index.html | 0001156039-26-000074 |
| Document: 0001156039-26-000074.txt | 0001156039-26-000074 |
Track record
19 reports on ELV
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +3.93% at T+5 after the Aug 27, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 2/10 Viewing Entry $429.48 Now $446.28 +3.91% settles Nov 18
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $425.62 to $429.69 Now $446.28 +4.85% ▲ +0.96% −1.64% vs SPY
- Oct 28, 202619d ago S-3ASR Neutral 3/10 Entry $422.02 to $432.00 Now $446.28 +5.75% ▲ +2.36% +7.09% vs SPY
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $439.95 to $420.07 Now $446.28 +1.44% ▼ −4.52% −3.96% vs SPY
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Sep 10, 20269w ago 8-K Neutral 3/10 Entry $416.54 to $414.26 Now $446.28 +7.14% ▼ −0.55% −0.05% vs SPY
- Aug 27, 202611w ago Institutional Cluster Bullish 6/10 Entry $399.11 to $414.78 Now $446.28 +11.82% ▲ +3.93% +3.66% vs SPY
- Aug 20, 202612w ago Court Ruling Neutral 2/10 Entry $400.54 to $394.43 Now $446.28 +11.42% ▼ −1.53% −2.00% vs SPY
- Aug 17, 202613w ago Court Ruling Neutral 1/10 Entry $396.54 to $397.14 Now $446.28 +12.54% ▲ +0.15% +0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers